Skip to content

Drug interactions

Melphalan + Tofacitinib

Severity: Major

Melphalan and Tofacitinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Melphalan causes marked myelosuppression and immunosuppression, and tofacitinib adds further immune suppression. The combination raises the risk of serious infections and prolonged cytopenias.

What this interaction means in plain words

Melphalan and Tofacitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Melphalan belongs to Oncology; Tofacitinib belongs to Musculoskeletal.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic immunosuppression and bone marrow suppression.

What to do

Avoid concurrent use and hold tofacitinib around melphalan therapy. If combined, monitor blood counts and infection signs closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Melphalan and Tofacitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Melphalan with Tofacitinib?

MediHelp rates the interaction as major. Melphalan and Tofacitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Melphalan causes marked myelosuppression and immunosuppression, and tofacitinib adds further immune suppression. The combination raises the risk of serious infections and prolonged cytopenias.

How serious is the interaction between Melphalan and Tofacitinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use and hold tofacitinib around melphalan therapy. If combined, monitor blood counts and infection signs closely.

What other medicines interact with Tofacitinib?

MediHelp also lists interactions of Tofacitinib with, for example, Baricitinib, Cladribine, Upadacitinib. The full list is on the Tofacitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in